BRIEF—AmerisourceBergen agrees to pay $625 million in criminal case

AmerisourceBergen has settled with the US government over an investigation related to pre-filled syringes, agreeing to pay $625 million on top of a $260 million criminal penalty.

A subsidiary of the drugs wholesaler admitted to producing packaged syringes of cancer drugs at a facility that was not registered with the US Food and Drug Administration, between 2005 and 2014, as well as illegally dispensing syringes based on order forms that had not been signed by a physician.

The company has already disclosed a $575 million reserve for civil liabilities.

The terms are still being negotiated and must be confirmed by a court.